Skip to content
MarketScale
‹ Back to IndustriesHealthcare

How Risk Screening Ultimately Reduces Overall Healthcare Costs & Improves Results

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

Whether it’s from a health study we hear on the news or an anecdote from a friend or family member, we all know that catching a health condition early can make all the difference in improving our quality of life and preventing complications, hospitalizations, or worse. And one of the most powerful tools available for the early diagnosis of disease is risk screening. So if risk screenings are so valuable, why don’t patients take advantage of these preventative services more often? Let’s take a look.

The High Cost of Waiting

Studies have shown that early detection of certain cancers and other chronic diseases through screening can reduce mortality by 15 to 20 percent. Not only does risk screening prevent complications by diagnosing health conditions early, it can actually help patients—and the healthcare system as a whole—save money. For example, in 2012 Alan Katz, Executive Vice President of SeeChange Health, testified that the average annual cost of early-stage treatment of breast cancer for a single patient is about $14,000 per year compared with $61,000 for late-stage treatment. Other examples of risk screening procedures that help drive down healthcare costs include colonoscopiespulmonary embolism risk assessment, and screenings for obesity, and tobacco and alcohol use.

So Why Isn’t Risk Screening Used More Often?

Out of pocket insurance costs are a top reason more people don’t schedule risk screenings. According to Thompson Reuters, the costs of mammograms, colonoscopies, and MRIs for Americans with employer-sponsored insurance can be two to three times higher than the median price in the same market. In addition, patients may simply be unaware of the specific risk screenings that are available to them because they do not regularly communicate with a primary care physician. Finally, when a patient does decide to get a screening, they may find the process for scheduling an appointment cumbersome and time-consuming.

ChartLogic Has the Tools to Make Scheduling Risk Screenings Easier

ChartLogic’s Connect Patient is a multifunction patient portal and communications platform that works with any device or browser. Physicians and patients can use this powerful technology tool to quickly and easily engage, enhancing the overall patient experience and improving quality by allowing patients to be more active participants in their own care. Patients can easily schedule appointments, send and receive messages from their doctor, view lab results, request prescription refills, and make payments. Best of all, Connect Patient integrates with ChartLogic’s comprehensive ambulatory EHR suite that includes Electronic Medical Records, Practice Management, and Billing Services.

Read more at chartlogic.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Wearables, AI diagnostics, and cybersecurity converge as healthcare's operational pressure points in 2026

Wearables, AI diagnostics, and cybersecurity converge as healthcare's operational pressure points in 2026

Wearable technology, AI diagnostics, and cybersecurity are becoming critical operational areas in healthcare by 2026. Companies like Samsung and GE HealthCare are advancing in these fields with new technologies, while cybersecurity incidents like the AnMed attack highlight the vulnerabilities in health systems. Healthcare providers must prioritize innovation and security to adapt to these emerging challenges.

  • 01Samsung's FDA-cleared Galaxy Ring represents an advancement in wearable health technology.
  • 02GE HealthCare has introduced a new AI-enabled ultrasound system.
  • 03The AnMed cyberattack underscores the urgent need for robust cybersecurity measures in healthcare.

Aug 13, 2026

TSP: Yvonne Commodore-Mensah

TSP: Yvonne Commodore-Mensah

The article discusses topics within the healthcare industry, focusing on contributions and insights from professionals in the field. It may delve into innovative practices or emerging trends shaping the sector. The discussion could also include expert opinions and potential strategies for improvement.

Aug 13, 2026

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

Generative AI is accelerating drug discovery processes, significantly reducing timelines from years to mere months. Clinical operators must adapt to this rapid change as AI-designed solutions become integral to the healthcare pipeline.

  • 01Generative AI is capable of reducing drug discovery timelines from years to months.
  • 02The integration of AI into healthcare is necessitating changes in clinical operations.
  • 03AI-informed patients are becoming more common in clinical settings.

Aug 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512